Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may enhance the drug's ability to manage blood glucose, potentially offering improved outcomes for individuals with type 2 diabetes. Further study is underway to fully evaluate the long-te